Bank of Industry Secures €50 Million from European Investment Bank for Healthcare Funding
The Bank of Industry (BoI), Nigeria's primary development finance institution, has successfully secured a substantial €50 million loan facility from the European Investment Bank (EIB). This strategic funding is specifically earmarked to bolster and strengthen Nigeria's healthcare and pharmaceutical sector, addressing critical gaps in the nation's medical infrastructure.
Strategic Objectives and Long-Term Financing
This significant financial injection is designed to provide long-term, sustainable financing to healthcare and pharmaceutical businesses operating across Nigeria. The primary goals include enhancing local manufacturing capabilities, improving supply chains for essential medicines and vaccines, and reducing the country's heavy reliance on imported pharmaceutical products. By focusing on domestic production, the initiative aims to create a more resilient and self-sufficient healthcare ecosystem.
Alignment with National Health Priorities
The Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) played a pivotal advisory role in structuring this deal, ensuring that the facility aligns seamlessly with Nigeria's national health priorities and overarching policy goals. This collaboration underscores a concerted effort to integrate international funding with local strategic objectives, maximizing the impact of the investment.
Leadership and Vision for Sustainable Impact
Dr Olasupo Olusi, the Managing Director of the Bank of Industry, emphasized that this partnership with the European Investment Bank is meticulously crafted to deliver "sustainable and long-term impact" through robust collaboration between the public and private sectors. He highlighted that such initiatives are crucial for fostering economic growth, improving healthcare accessibility, and building a more robust pharmaceutical industry in Nigeria.
Broader Context and Institutional Track Record
This healthcare funding initiative is part of a broader, comprehensive push to transform Nigeria's medical landscape by boosting domestic production capacity and ensuring a steady supply of essential health commodities. The Bank of Industry, with its proven track record, has supported over one million enterprises and disbursed more than N1.27 trillion between 2023 and 2025, demonstrating its capacity to manage large-scale developmental projects effectively.
The €50 million facility from the European Investment Bank represents a significant milestone in Nigeria's journey towards healthcare self-sufficiency, promising to catalyze growth, innovation, and resilience in the pharmaceutical sector while addressing pressing public health needs.
